amfAR is currently accepting applications for its Therapeutic Immune Reprogramming in Cancer Request for Proposals 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it
This amfAR funding opportunity supports cancer immunology research focused on immune reprogramming.The call is designed for researchers investigating how ineffective immune states in cancer can be restored, redirected, or amplified to improve anti-tumor immunity.It supports mechanistic, preclinical, and translational projects with strong relevance to future therapeutic development.
Apply for amfAR - Therapeutic Immune Reprogramming in Cancer Request for Proposals
Need help with your application?